First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy

Name: First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
License: Public Domain

SciClone Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

egfr mutation positive non small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 172301
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.